Sino Biopharmaceutical Ltd (1177)

3.84
-0.07(-1.79%)
  • Volume:
    16,088,774
  • Bid/Ask:
    3.83/3.84
  • Day's Range:
    3.80 - 3.92

1177 Overview

Prev. Close
3.91
Day's Range
3.8-3.92
Revenue
60.19B
Open
3.92
52 wk Range
3.58-6.3
EPS
0.43
Volume
16,088,774
Market Cap
70.97B
Dividend (Yield)
0.10
(2.60%)
Average Vol. (3m)
34,965,652
P/E Ratio
8.50
Beta
0.467
1-Year Change
-34.18%
Shares Outstanding
18,481,249,353
Next Earnings Date
Nov 28, 2022
What is your sentiment on Sino Biopharmaceutical?
or
Market is currently closed. Voting is open during market hours.

Sino Biopharmaceutical Ltd Company Profile

Sino Biopharmaceutical Ltd Company Profile

Employees
25579
Market
Hong Kong

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.

Read More

Analyst Price Target

Average6.57 (+71.09% Upside)
High12.01
Low3.61
Price3.84
No. of Analysts25
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyBuyBuyStrong Sell
  • HSBC Global Research: SINO BIOPHARM Acquisition of F-Star Should Improve Pipeline, Rating Buy
    0
    • HSBC Global Research Cuts SINO BIOPHARM TP to $9, Rated Buy
      0
      • UBS Adds SINO BIOPHARM TP to $11.6, Rated Buy
        0
        • M Stanley Trims CHINA CINDA TP to $1.63; Rated Equalweight
          0
          • Daiwa Axes SINO BIOPHARM TP to $11; Rated Buy
            0
            • SINO BIOPHARM Shr Once Rebounds Over 9% as Interim NP May Hike Over 5x
              0
              • SINO BIOPHARM Repurchases $28.53M Shrs; Tse Ping, Tse Hsin Splurge Over $100M to Add Stakes
                1
                • WHO agree SinoVac into EUA list at Jun 01, that Sino Biopharm have 15.3%
                  0
                  • Macquarie Upgrades SINO BIOPHARM to *Outperform* with $10.46 TP
                    0
                    • JPM Raises SINO BIOPHARM TP to $13.5; Rated ***Overweight***
                      1